Carson Wealth (CWM LLC)
NRIX icon

Carson Wealth (CWM LLC)’s Nurix Therapeutics NRIX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Buy
841
+667
+383% +$11.1K ﹤0.01% 4674
2025
Q4 		$3K Buy
174
+147
+544% +$2.11K ﹤0.01% 4997
2025
Q3 		$0 Sell
27
-29
-52% -$301 ﹤0.01% 5449
2025
Q2 		$1K Buy
56
+48
+600% +$519 ﹤0.01% 5041
2025
Q1 		$0 Sell
8
-73
-90% -$1.22K ﹤0.01% 5150
2024
Q4 		$2K Sell
81
-192
-70% -$4.4K ﹤0.01% 4581
2024
Q3 		$6K Buy
273
+131
+92% +$2.97K ﹤0.01% 4020
2024
Q2 		$3K Buy
+142
New +$2.21K ﹤0.01% 4096
2023
Q3 		– Sell
-35
Closed – – 4427
2023
Q2 		$0 Hold
35
– – ﹤0.01% 4374
2023
Q1 		$0 Hold
35
– – ﹤0.01% 4254
2022
Q4 		$0 Buy
+35
New +$422 ﹤0.01% 4158

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NRIX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Nurix Therapeutics (NRIX) stake by 383% in Q1 2026, buying an estimated $11.1K and bringing the position to 841 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #4674.

Carson Wealth (CWM LLC) first reported a position in NRIX in Q4 2022 and has held it in 11 quarters since. 196 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 841 shares of Nurix Therapeutics worth $13K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 667 Nurix Therapeutics shares in Q1 2026, an estimated $11.1K.
  • Nurix Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4674 holding.
  • Carson Wealth (CWM LLC) first reported a position in Nurix Therapeutics in Q4 2022 and has held it in 11 quarters since.
  • 196 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.